CIK 0000818033
- Accelerated filer
HERON THERAPEUTICS, INC. /DE/
Sign in to watch- Ticker
- HRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 942875566
- Phone
- +1 858-251-4400
- Business address
- 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
- 4 Grant or award Director acquired 10,452 shares (grant or award)
- 4 Open-market sale Director sold 250 shares at $9.73 ($2,432)
- 4 Grant or award Director acquired 10,452 shares (grant or award)
- 4 Grant or award Director acquired 10,452 shares (grant or award)
- 4 Shares withheld for taxes EVP, Chief Operating Officer gave up 433 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 963 shares (to pay taxes)
- 4 Shares withheld for taxes President & CCO gave up 433 shares (to pay taxes)
- 4 Shares withheld for taxes VP, Chief Accounting Officer gave up 191 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Drug Development gave up 433 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 300 shares at $12.31 ($3,692)
- 4 Open-market sale Director sold 250 shares at $12.30 ($3,074)
- 4 Other acquisition EVP, Chief Operating Officer acquired 1,530 shares (other)
- 4 Other acquisition Chief Executive Officer acquired 1,529 shares (other)
- 4 Other acquisition President & CCO acquired 971 shares (other)
- 4 Other acquisition VP, Chief Accounting Officer acquired 1,530 shares (other)
- 4 Shares withheld for taxes EVP, Drug Development gave up 433 shares (to pay taxes)
- 4 Open-market sale Director sold 300 shares at $15.20 ($4,559)
- 4 Open-market sale Director sold 250 shares at $15.20 ($3,801)
Page 10 of 30 · 585 filings